Abstract
An increase in dementia cases is producing significant medical and economic pressure in many communities. This growing problem calls for the application of AI-based technologies to support early diagnostics, and for subsequent non-pharmacological cognitive interventions and mental well-being monitoring. We present a practical application of a machine learning (ML) model in the domain known as ‘AI for social good’. In particular, we focus on early dementia onset prediction from speech patterns in natural conversation situations. This paper explains our model and study results of conversational speech pattern-based prognostication of mild dementia onset indicated by predictive Mini-Mental State Exam (MMSE) scores. Experiments with elderly subjects are conducted in natural conversation situations, with four members in each study group. We analyze the resulting four-party conversation speech transcripts within a natural language processing (NLP) deep learning framework to obtain conversation embedding. With a fully connected deep learning model, we use the conversation topic changing distances for subsequent MMSE score prediction. This pilot study is conducted with Japanese elderly subjects within a healthy group. The best median MMSE prediction errors are at the level of 0.167, with a median coefficient of determination equal to 0.330 and a mean absolute error of 0.909. The results presented are easily reproducible for other languages by swapping the language model in the proposed deep-learning conversation embedding approach.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
The study was reviewed and approved by the RIKEN Ethics Committee in Wako-shi, Saitama, Japan. RIKEN Center for Advanced Intelligence project, where the research was conducted, does not require clinical study registration. The study focuses on machine-learning-based biomarker prediction without a therapeutic application.
Funding Statement
This research was supported in part by the KAKENHI, the Japan Society for the Promotion of Science Grant No. JP18K18140 (MSA), JP18KT0035 (MOM), JP19H01138 (MOM), JP20H05022 (MOM), JP20H05574 (MOM), and the Japan Science and Technology Agency AIP Trilateral AI Research Grant No. JPMJCR20G1 (MOM, TMR).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was reviewed and approved by the RIKEN Ethics Committee in Wako-shi, Saitama, Japan. The older Japanese adults were recruited from the aged people support focused Tokyo Silver Human Resources Center. The 65 elderly subjects participated voluntarily in the study, and they all gave informed written consent.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The recorded speech data is not available due to privacy and ethical limitations.
